Related references
Note: Only part of the references are listed.Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes
Pier Paolo Piccaluga et al.
BLOOD (2011)
Alteration of MicroRNAs Regulated by c-Myc in Burkitt Lymphoma
Anna Onnis et al.
PLOS ONE (2010)
Lessons from clinical trials in African Burkitt lymphoma
Ian Magrath
CURRENT OPINION IN ONCOLOGY (2009)
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials
Wolfram Klapper et al.
BLOOD (2008)
High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma - Comparison of results in human immunodeficiency virus-infected and noninfected patients
Albert Oriol et al.
CANCER (2008)
Malignant lymphomas (ML) and HIV infection in Tanzania
Amos R. Mwakigonja et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation
E. Leucci et al.
JOURNAL OF PATHOLOGY (2008)
Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors
Giulia De Falco et al.
BLOOD (2007)
Diff-use large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial
Ilske Oschlies et al.
BLOOD (2006)
Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas
C Bellan et al.
BLOOD (2005)
AIDS-associated cancer in developing nations
J Orem et al.
CURRENT OPINION IN ONCOLOGY (2004)
Share Paper
